Ceren Ozek, PhD
About Ceren Ozek, PhD
Ceren Ozek, PhD, is a Senior Drug Discovery Scientist at BenevolentAI in London, with over 10 years of experience in neuroscience research.
Title
Ceren Ozek, PhD, is currently a Senior Drug Discovery Scientist at BenevolentAI in London, England, United Kingdom. She began this role in January 2022.
Current Company
Ceren Ozek works at BenevolentAI, a company based in London, England, United Kingdom. BenevolentAI specializes in applying artificial intelligence to accelerate drug discovery and development.
Previous Positions
Prior to joining BenevolentAI, Ceren Ozek served as a Senior Research Scientist at MiNA Therapeutics in 2021 for 9 months. She also held research roles at Harvard University, working as a Research Associate from 2020 to 2021 for 3 months, and as a Postdoctoral Fellow from 2016 to 2020 for 4 years.
Education and Expertise
Ceren Ozek earned her Doctor of Philosophy (PhD) in Neuroscience from the University of Pennsylvania, where she studied from 2010 to 2015. She also obtained a Bachelor of Science (B.Sc.) in Biological and Biomedical Sciences from Sabanci University, completing her studies there from 2006 to 2010. Ozek has extensive experience in in vivo biochemical, histological, and behavioral studies using both wild type and transgenic mice, as well as in vitro studies with primary mouse and human cells.
Research Background
Ceren Ozek has focused her research on aging in the brain, Alzheimer’s disease, and obesity. She has over 10 years of experience in neuroscience research, including conducting in vitro biochemical and histological studies using various cell types and in vivo studies involving both wild type and transgenic mice.